Risk Of Developing Liver Cancer After HCV Treatment

Thursday, August 18, 2011

"Telaprevir Alone or W-Peg/Riba Reduces HCV RNA in Patients With Geno 2 But Not Geno 3

Also View; Aug 18 Patient video;New hepatitis C Drugs and Resistance





Dr. Graham Foster discusses his manuscript "Telaprevir Alone or With Peginterferon and Ribavirin Reduces HCV RNA in Patients With Chronic Genotype 2 But Not Genotype 3 Infections."


http://www.youtube.com/watch?v=UygWzHN9Pgc

No comments:

Post a Comment